| http://www.w3.org/ns/prov#value | - disease, type I and type II diabetes, lymphoid leukemia and other forms of cancer, multiple sclerosis and autoimmune diseasesUS8097621Jun 10, 2009Jan 17, 2012Pfizer Inc.Pyrazolo[4,3-d]pyrimidines as phosphodiesterase inhibitorsWO2002059126A1 *Dec 29, 2001Aug 1, 2002Hans-Michael EggenweilerProcess for the preparation of a pyrazolo[4,3-d]pyrimidine derivativeWO2002062343A2 *Jan 14, 2002Aug 15, 2002H
|
